MAFM
BNTX icon

Mid Atlantic Financial Management’s BioNTech BNTX Stock Holding History

Mid Atlantic Financial Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$422K Sell
1,547
-76
-5% -$24.2K 0.03% 522
2021
Q2 		$363K Buy
+1,623
New +$306K 0.02% 590

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Mid Atlantic Financial Management's BNTX Position: Q3 2021 in Review

Mid Atlantic Financial Management reduced its BioNTech (BNTX) stake by 4.7% in Q3 2021, selling an estimated $24.2K and leaving 1,547 shares worth $422K. The position accounts for 0.03% of the portfolio, ranked #522.

Mid Atlantic Financial Management first reported a position in BNTX in Q2 2021 and has held it in 2 quarters since. 335 funds tracked by Wall St. Rank hold BNTX as of Q3 2021.

  • Mid Atlantic Financial Management held 1,547 shares of BioNTech worth $422K as of Q3 2021.
  • Mid Atlantic Financial Management sold 76 BioNTech shares in Q3 2021, an estimated $24.2K.
  • BioNTech made up 0.03% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #522 holding.
  • Mid Atlantic Financial Management first reported a position in BioNTech in Q2 2021 and has held it in 2 quarters since.
  • 335 funds tracked by Wall St. Rank held BioNTech as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.